Nanoparticles in Drug Loading Encapsulation and Adsorption-2019-03-31-20-59 PDF
Nanoparticles in Drug Loading Encapsulation and Adsorption-2019-03-31-20-59 PDF
Nanoparticles in Drug Loading Encapsulation and Adsorption-2019-03-31-20-59 PDF
XX(X):1–3
NANOPARTICLES IN DRUG LOADING, ©The Author(s) 0000
Reprints and permission:
ENCAPSULATION AND ADSORPTION. sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/ToBeAssigned
www.sagepub.com/
Laura Valentina Buendía Quintero, María Paula García Forero, Sara Castro Olaya, Laura
Sofía Espinosa Moreno and Mariana Salgado Sánchez
Abstract
The importance of nanotechnology has been developed by groups of investigation, chemists and scientific, who try to
break traditional methods barriers with the implementation of this new technologies. One of the most investigated field
is the use of nanoparticles in pharmaceutics, focusing efforts on the prevention and solution of terminal diseases. This
article explains the process of medicines fabrication until the internal biological process, the benefits and, complications
that need a further research. There was made a recompilation of academic publications and reviews, that have been
investigated through the last decades, in order to understand in depth how nanotechnology is evolving and will continue
improving in different fields. It is concluded that the last investigation have shown improvements in drugs delivery, lasting
longer periods of time with less frequent dosing (sustained release) and having greater precision and penetration in
difficult access tissues; all of these, being useful to create customizable and safer treatments options.
Keywords
Nanoparticles, Nanosphere, Nanocapsules, Polymers, Drug loading, Drug encapsulation, Drug adsorption, Intercellular
delivery, Drug targeting, Nanotheragnostics
factors. The particle must be large so that no leakage occurs for therapeutic use in humans and is so useful because
in the blood capillaries, but not very large, as this would produces effective hydrolysis in human body, leading them
cause the particle to become susceptible to the clearance of to many investigations in search of better alternatives for
macrophages. When manipulating the surface, clearing and cancer prevention and cure. PLGA nanoparticles are mostly
extension of the aggregation can be controlled. prepared by methods that include the dissociation or blend
By controlling bioavailability, reducing clearance and of substances, such as emulsification-diffusion, emulsion-
increasing stability, the medicine can be obtained from evaporation, deposition and nanoprecipitation.
tissues in the body that were previously inaccessible, thanks The PLGA are divided in other subcategories according
to the size and surface properties of nanoparticles. The to the type of drug that is being encapsulated, including
release of drugs depends on the temperature, pH, solubility, anticancer, diabetes, psychotic, hormones and tetanus drugs.
the diffusion of medicines by means of the matrix of The first and most investigated are anticancer drugs; these
nanoparticles and the erosion of the matrix. loaded nanoparticles oversee the components, especially the
ones with instability and insolubility properties, in order
to have a better penetration, cellular internalization and
Drug Loading endosomal escape.
Loading is the process by which different drugs are charged The second one is diabetes, characterized by the
in the nanoparticle weight, being the first step in the drug maintenance of insulin levels for a long-term period and
delivery chain. Selecting the different loading methods improving the oral administration way with nanoparticles
depends on the drug loading factors, which are determined and additives that fit with medical specifications. The
by the specifications of medicine. These specified conditions third one is the encapsulation of tetanus, appropriate to
are important specially in processes with nanoparticles, prevent the bacteria penetration and create effectively the
because they allow a total control of conditions such immunoreactive antigen, in order to allow the body, react
as pressure or temperature if they are correctly chosen. against the bacteria by itself. There are many others
The advantage of the new nanotechnologies’ investigations nanoparticules such as, Polylactic acid (PLA), Poly-ε-
is then, leading to an increase in the efficiency of the caprolactone (PCL), Chitosan, Gelatin, and, some options
drug, bioavailability, tolerability, easier administration and that are nowadays unauthorized for human application, being
reaching the major capacity in the total weight, without this the case of the Poly-alkyl-cyano-acrylates (PAC).
inducing non wanted reactions.
One of the most important advances in nanoparticles for
drug loading are nanocapsules, spherical structures enclosed
Adsorption
by different polymer membranes. With nanocapsules, the Due to the great impact of nanotechnology in the
improvement in loading drugs is a huge advantage in health industry, additional progresses were made in the
medicine, having unique characteristics as the dissolution of development of the administration of targeted drugs because
different densities drugs and a wide number of nanomaterials the nanoparticles are responsible for breaking those agents
that increase the stability and allow the whole drug to reach who damaged the tissues, it can be active or passive
and act in the human body, not before. segmentation according to their concentration gradient. An
efficient system must be able to reach, recognize and deliver
its load to pathological tissues avoiding the damage caused
Encapsulation by the drug.
Polymeric nanoparticles have been synthesized using various Drug nanoparticles molecules can work as modifiers on
methods to encapsulate depending on the purpose of its the human body in order to achieve the best surface for
application and the type of drug. Nanoparticles have an the desired drug action. Some of these characteristics are
extensive use in nanoencapsulation as in many bioactive hard to find in conventional pharmaceutic methods, but
molecules and medicinal drugs that leads to the develop in with nanoparticles, adsorption has improved substantially.
nanomedicine. Improvements include, the increment of the retention time
Biodegradable polymeric nanoparticles are essential in in the bloodstream and improving the bioavailability of each
the drug delivery system, given that such particles pro- kind of medicine doses. Hence, nanoparticles are helping
vide control and sustainability. Moreover, nanomedicines lots of people with terminal diseases to think about a
are not toxic and stable in the circulatory system. Most possible solution, each time with less side effects and more
of biodegradable nanomedicines encapsulation are repre- effectiveness.
sented in nanospheres or inside a nanocapsule with com-
ponents like nonchromogenic, nonimmunogenic, noninflam-
matory, which does not activate neutrophils, biodegradable,
Contradictions
avoid reticuloendothelial system and applicable to various Even though nanotechnology has been a key for scientific
molecules such as drugs, proteins, peptides, or nucleic acids. advances and development in the pharmacy industry, there
The classification of nanoparticles nanoencapsulation, is an urgent need for changes in this technology. For
varies according to their properties, which are the ones more efficient loading and controlled release of drugs,
in charge of giving more efficiency to the drug. The there must be an introduction of bio materials which
first and most used type is known with the abbreviation count with an effective delivery system. In addition, multi
PLGA, which means Poly-D, L -lactide-co-glycolide). It functional nanoparticles design is a challenge for the
is approved by the FDA (Food and Drug Administration) scientific community. For example, the combination of
many drugs acting together on biological target (such as, 2: nanostructures for drug delivery. Tropical Journal of
antiangiogenic compound and a DNA interlope agent), Pharmaceutical Research, 8(3).
this could cause an enhanced therapeutic activity, more Kumari, A., Yadav, S. K., & Yadav, S. C. (2010).
than a simple addition of the pharmacological activity of Biodegradable polymeric nanoparticles based drug delivery
each compound. A drug in association with an agent in systems. Colloids and Surfaces B: Biointerfaces, 75(1),
the same nanoparticles that comes with a personalized 1–18. DOI: https://doi.org/10.1016/J.COLSURFB.2009.09.
treatment for the patient depending on the diagnosis 001
(“Nanotheragnostics”). Furthermore, the need of new Couvreur, P. (2019). Nanoparticles in drug delivery:
concepts for nanoparticles to deliver nucleic acids efficiently Past, present and future. [online] ScienceDirect. Available
into cells, as viral particles for gene delivery are still much at: https://www.sciencedirect.com/science/article/pii/S0169
more effective. 409X12001500 [Accessed 30 Mar. 2019].
Although has allowed us to get through many obstacles
in pharmacy, such as protecting drugs from degradation and Author Biographies
metabolization, the control of its release and its distribution
as well as the delivery into intracellular compounds. A Laura Valentina Buendía Quintero Estudiante Ingeniería química
lot of improvements remains before nanoparticles can
be considered as the standard drug given by medical María Paula García Forero Estudiante de Ingeniería química
institutions. However, it is believed in the scientific
community that the formulation of drugs as nanoparticles Sara Castro Olaya Estudiante de Ingeniería química
could be seen as a solution for the pharmaceutical industry’s
drug discovery researchers. Laura Sofía Espinosa Moreno Estudiante de Ingeniería química
References
Parhizkar, M., Mahalingam, S., Homer-Vanniasinkam, S., &
Edirisinghe, M. (2018). Latest developments in innovative
manufacturing to combine nanotechnology with healthcare.
Rizvi, S. A., & Saleh, A. M. (2018). Applications of
nanoparticle systems in drug delivery technology. Saudi
Pharmaceutical Journal, 26(1), 64-70.
Nanotechnology Strategies To Advance Outcomes in
Clinical Cancer Care
Christopher M. Hartshorn, Michelle S. Bradbury, Gregory
M. Lanza, Andre E. Nel, Jianghon Rao, Andrew Z. Wang,
Ulrich B. Wiesner, Lily Yang, and Piotr Grodzinski
ACS Nano 2018 12 (1), 24-43 DOI:
10.1021/acsnano.7b05108
V. Raffa, O. Vittorio, C. Riggio & A. Cuschieri (2010)
Progress in nanotechnology for healthcare, Minimally
Invasive Therap & Allied Technologies, 19:3, 127-135,
DOI:10.3109/13645706.2010.48109
Ochekpe, N. A., Olorunfemi, P. O., & Ngwuluka,
N. C. (2009). Nanotechnology and drug delivery part